Genasys, Inc. GNSS 深 沪
等待开盘 05-21 09:30:00 美东时间
1.90
0.000
0.00%
华盛通- 最 高1.94
- 今 开1.90
- 成交量 9.35万股
- 最 低 1.8707
- 昨 收 1.90
- 总市值 8652.98万
- 52周最高 2.70
- 市盈率 静 --
- 换手率 0.21%
- 52周最低 1.40
- 委 比 70.95%
- 总股本 4554.20万
- 历史最高 8.325
- 量 比 0.27
- 振 幅 3.65%
- 历史最低 0.77
- 每 手 1
- 风险率 0.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Genasys Extends Term Loan Maturity for Short-Term Flexibility
The latest update is out from Genasys ( ($GNSS) ). On May 12, 2026, Genasys Inc...
05-15 04:47
Genasys shares are trading higher after the company reported better-than-expected Q2 EPS results.
Genasys shares are trading higher after the company reported better-than-expect...
05-15 04:37
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Genasys Appoints Bill Dodd Board Chairman, Succeeding Richard H. Osgood
Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, today announced that Bill Dodd has been appointed chairman of the company's board of directors following the retirement of Richard H. Osgood
03-23 21:05
Genasys appoints Bill Dodd as board chairman
Genasys appoints Bill Dodd as board chairman Genasys appointed Bill Dodd as chairman of its board following the retirement of Richard Osgood. Dodd has served on the board since May 2024 and previously served in the California State Senate from December 2016 to December 2024. His earlier public servi
03-23 21:02
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Wall Street analysts changed outlook on top names. See ratings page for upgrades, downgrades, and initiations. Analysts recommend H2O, KRMN, GNSS, WCN, and WM stocks.
03-14 01:04
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Ascendiant Capital Maintains Buy on Genasys, Raises Price Target to $5.5
Ascendiant Capital analyst Edward Woo maintains Genasys (NASDAQ:GNSS) with a Buy and raises the price target from $5.25 to $5.5.
03-11 17:57
Genasys Receives $2M Order From Singapore Navy For LRAD 950NXTs
Genasys Inc. (NASDAQ:GNSS), the global leader in Protective Communications, today announced a $2.0 million order to equip new Republic of Singapore Navy (RSN) unmanned surface vessels (USVs) with remotely operated LRAD
02-12 20:46
